In vitro activity of aztreonam-avibactam against a global collection of Gram-negative pathogens from 2012 and 2013.
about
Interaction of Avibactam with Class B Metallo-β-Lactamases.In Vitro Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains.Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa.Changes in the Frequencies of β-Lactamase Genes among Enterobacteriaceae Isolates in U.S. Hospitals, 2012 to 2014: Activity of Ceftazidime-Avibactam Tested against β-Lactamase-Producing Isolates.Successful Treatment of Bloodstream Infection Due to Metallo-β-Lactamase-Producing Stenotrophomonas maltophilia in a Renal Transplant Patientβ-Lactams and β-Lactamase Inhibitors: An Overview.A review of the pharmacokinetics and pharmacodynamics of aztreonam.The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?The rapid spread of carbapenem-resistant Enterobacteriaceae.Avibactam Restores the Susceptibility of Clinical Isolates of Stenotrophomonas maltophilia to Aztreonam.In Vitro Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015.First Report of a Verona Integron-Encoded Metallo-β-Lactamase-Producing Klebsiella pneumoniae Infection in a Child in the United StatesIn Vitro Activity of Imipenem against Carbapenemase-Positive Enterobacteriaceae Isolates Collected by the SMART Global Surveillance Program from 2008 to 2014.Were all carbapenemases created equal? Treatment of NDM-producing extensively drug-resistant Enterobacteriaceae: a case report and literature review.New Antibiotics in Development Target Highly Resistant Gram-Negative Organisms.Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.Avibactam Pharmacokinetic/Pharmacodynamic Targets.Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors
P2860
Q34533834-586381DC-2BFA-45A9-812E-5BB5CF9DD7CFQ36571892-F80297F7-F24E-49C5-8E22-00E1FC8BE984Q36571962-2B33D86F-4097-4FEF-9A6E-273DEAE6E19BQ37120191-A6FE37B0-D5E9-430D-B704-397D6471FC86Q37203771-05C2111F-6C7C-4B83-BDD7-E8271538CB9BQ38872374-F7124FB5-0A70-4C5A-B5AD-FB336431511AQ38873850-56A2ECD1-A86D-49FD-A3A8-6E7AB020E5F4Q38892589-147D1278-9467-46C8-875B-10216208552EQ39027434-9A90C90D-0FC8-47E8-A2C6-34074B1E8801Q40091720-8C90AA83-15B9-40F1-B6C5-9C167DA92E3EQ40166206-2072DD04-7E4B-4031-9942-BE43380B8990Q40686933-3F83163D-DDD1-420D-902B-A62FB8C78D52Q45223510-8F96C121-71D6-42E2-8733-0090B1995971Q46152898-F0D6D3AB-C4A8-4BCF-A5F3-9AD65B4965C2Q49540457-73611D6E-56CB-474A-87FD-190F8D7F48AEQ52591821-AC953512-4A7D-40D0-AA57-3322172B572EQ52611981-91FCA8F4-5A08-463A-B7B9-B92CC36A3A68Q52695014-5CD65641-6EFF-4153-9682-8F4A0E27FF18Q58641878-C110F51B-3F16-4D10-B572-A5E0B54BB2F5
P2860
In vitro activity of aztreonam-avibactam against a global collection of Gram-negative pathogens from 2012 and 2013.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
In vitro activity of aztreonam ...... pathogens from 2012 and 2013.
@en
type
label
In vitro activity of aztreonam ...... pathogens from 2012 and 2013.
@en
prefLabel
In vitro activity of aztreonam ...... pathogens from 2012 and 2013.
@en
P2093
P2860
P356
P1476
In vitro activity of aztreonam ...... pathogens from 2012 and 2013.
@en
P2093
Daniel F Sahm
Douglas J Biedenbach
Krystyna Kazmierczak
Samuel K Bouchillon
P2860
P304
P356
10.1128/AAC.00206-15
P407
P577
2015-05-11T00:00:00Z